← Evidence map

ArticleCancer research2023

Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma.

Deepak Rohila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37306759